According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market.
South Korea
Domestic companies from South Korea are transitioning quickly to an export-oriented stance and as reported by the Korean Pharmaceutical Traders Association (KPTA), exports of domestic finished products is growing with a total volume of $2.6 billion last year (2017). Additionally, domestic active pharmaceutical ingredients (APIs) are witnessing steady growth with a total volume of $1.6 billion exported in 2017.